Filter Results:
(33)
Show Results For
- All HBS Web (342)
- Faculty Publications (228)
Show Results For
- All HBS Web (342)
- Faculty Publications (228)
Page 1 of 33
Results →
Sort by
- 01 Mar 2011
- News
Fixing What Ails the Drug Industry
In 2008, private investors and the National Institutes of Health plowed more than $100 billion into pharmaceutical research. And yet, “We’re not seeing the new diagnostics, treatments, preventative approaches, and cures that we might have... View Details
- 01 Mar 2007
- News
Daniel Vasella
portfolio of product lines, setting Novartis apart from its global competitors. Although initially regarded by critics as too inexperienced to lead a multinational pharmaceutical company, Vasella has triumphed. Three years ago he was... View Details
- 01 Sep 2007
- News
Alfred D. Chandler Jr. Remembered
England, and Germany by examining the 200 largest corporations in those countries. In 2001, Chandler wrote Inventing the Electronic Century: The Epic Story of the Consumer Electronics and Computer Industries, which focused on the fall of the Radio Corporation of View Details
- 01 Mar 2009
- News
A New Approach to Health-Care Reform
approach not just to insurance and reimbursement, but also to the places where medical services are delivered, the way we use technology, the way pharmaceuticals are developed, the way we educate medical professionals, and who performs... View Details
- 01 Jun 2012
- News
The Power of Philanthropy
When their son Joey died of cystic fibrosis in 1986 at age 12, Kathy and Joe O’Donnell (MBA 1971) vowed to fight the disease. O’Donnell, at the time the president of the Boston Concessions Group, joined with Vertex Pharmaceuticals and the... View Details
- 24 Apr 2014
- News
A passion for the sea doubles the percent of ocean set aside for conservation
Ernesto Bertarelli (MBA 1993), an America’s Cup–winning sailor and avid scuba diver, understands the importance of protecting marine ecosystems. The former owner and CEO of the pharmaceutical and biotechnology company Serono has provided... View Details
- 01 Dec 2004
- News
Capitalizing Poetry
Barr Photo courtesy Poetry Foundation In 2002, pharmaceutical heiress Ruth Lilly made a gift in excess of $100 million to the Modern Poetry Association (now the renamed Poetry Foundation). Tapped in February to figure out what to do with... View Details
- 01 Sep 2008
- News
Mara Aspinall
that personalized medicine brings. This is particularly important in fast-moving diseases, where the window for a positive outcome is small. What aspects of their business model do pharmaceutical companies need to redesign to hasten the... View Details
- 01 Feb 2002
- News
Health Industry Alumni Convene for Conference
and CEO of Mediconsulting, Inc., spoke about creating a better model for business collaborations between biotech and pharmaceutical firms. Said Klietmann, the conference's biotechnology chair and a lecturer in pathology at Harvard Medical... View Details
- 01 Mar 2006
- News
Using IT to Heal U.S. Health Care
Association’s conference held on campus in early November. The three-day conference included presentations by industry executives, government officials, and HBS faculty on topics ranging from trends in the biotech and pharmaceutical... View Details
- 01 Dec 2004
- News
Finding a Balance
Do the rules of business change when a company’s product holds the power of life or death over its customers? That’s a question students must consider when discussing “Cipla,” a case about a $325 million Indian pharmaceutical company that... View Details
- 01 Dec 2013
- News
Your Own Medicine
to the trade group Pharmaceutical Research and Manufacturers of America (PhRMA), only one of 5,000 to 10,000 experimental compounds make it to FDA approval, and just 2 of the 10 that get that approval... View Details
- 01 Sep 2006
- News
Gift of Gab
then delivered a prepared talk on a topic of their choice. Subjects ranged from the pharmaceutical industry to the relative merits of cats vs. dogs, while Kim’s presentation took a humorous yet thoughtful approach to lessons learned in... View Details
- 13 Jul 2020
- News
Locally Grown
pharmaceutical machinery sector. With the natural beauty of the Rocky Mountains as a backdrop for his career decision, Fenwick-Smith became increasingly interested in climate change and what the business community could do to make a... View Details
Keywords: April White
- 03 Nov 2016
- News
17 Ventures Join the Pagliuca Harvard Life Lab
Institute/HMS Nix – HBS, SEAS, Blavatnik Fellow PathoVax – HMS Piper Therapeutics – College, HBS Riparian Pharmaceuticals – College, SEAS Suono Bio – HMS UnNamed – HMS UrSure Inc. – HKS Vaxess Technologies, Inc. HBS, SEAS, HKS, HLS... View Details
- 01 Sep 2012
- News
What’s the Big Idea?
international divisions. “Goldman Sachs in New York is different from Goldman Sachs in Asia,” he observes, adding that the same is true for conglomerates operating in industries as different as pharmaceuticals and aircraft engines.... View Details
- 24 Apr 2014
- News
Giving hope and inspiration to cancer patients around the globe
Every new day is a good day for Kathryn E. Giusti (MBA 1985) since that morning in 1996 when her oncologist told her to get her affairs in order because she had a rare blood cancer, with three years to live. Leveraging her past experience as a View Details
- 01 Sep 2010
- News
Fair Trade
pharmaceuticals and software, and far above the average of all industries. Many apparent paradoxes add to the puzzle posed by the industry. While rarely considered fundamentally “bad,” such as the trade in narcotics or tobacco, the beauty... View Details
- 01 Feb 2002
- News
Telling the Electronic Century's Unfinished Story
and pharmaceutical industries. But the differences between those pairs of sectors were just too great. So the second book will examine this question: Why were the Japanese chemical and pharmaceutical... View Details
- 01 Dec 2003
- News
The Next Big Thing
life-sciences center of the world, by virtue of its unsurpassed “cluster” of world-renowned universities and teaching hospitals; medical-device, biotech, and pharmaceutical companies; financial firms; and skilled workers. “The leadership... View Details